Semaglutide

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom

Tighter U.S. enforcement has curtailed compounded sales, pushing former ingredient suppliers to pursue approved generics.